Baxter and Boston Scientific both participated in a series C round for the kidney disease-focused medical device maker, which has now raised $27m altogether.
US-based medical device maker TVA Medical completed a $15m series C round led by Baxter Ventures, the corporate venturing subsidiary of pharmaceutical company Baxter, yesterday.
Medical devices manufacturer Boston Scientific also took part in the round, investing alongside Santé Ventures, S3 Ventures, TriStar Technology Ventures and additional, unnamed investors.
Founded in 2008, TVA is working on minimally invasive treatments for end-stage renal disease. The company’s lead product, Everlinq EndoAVF, has received regulatory approval in the European Union for patients with…
